Clinical trial
Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid…
NCT00346567 · Rigshospitalet, Denmark, Other · Completed
Key facts
| NCT number | NCT00346567 |
|---|---|
| Title | Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT) |
| Official title | Clinical Trial: Backup With Combivir (AZT/3TC) or Single Dose (sd) Truvada (FTC/TDF) in Order to Avoid NNRTI Resistance After sd Nevirapine for the Prevention of Mother-to-child Transmission (MTCT) |
| Lead sponsor | Rigshospitalet, Denmark, Other |
| Collaborators | University of Copenhagen |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Zidovudine and Lamivudine (Combivir), Emtricitabine and Tenofovir (Truvada) |
| Enrollment | 566 |
| Start date | Jun 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Jun 30, 2006 |
| Last update posted | Feb 23, 2016 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: